A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation

A Phase 1, Open-Label, Randomized, Crossover Study Evaluating the Bioavailability of TAS-102 (Trifluridine/Tipiracil) Tablets Relative to an Oral Solution Containing Equivalent Amounts of Trifluridine and Tipiracil

The Journal of Clinical Pharmacology ◽

10.1002/jcph.856 ◽

2017 ◽

Vol 57 (6) ◽

pp. 751-759 ◽

Cited By ~ 1

Author(s):

Carlos R. Becerra ◽

Kenichiro Yoshida ◽

Hirokazu Mizuguchi ◽

Manish Patel ◽

Daniel Von Hoff

Keyword(s):

Crossover Study ◽

Phase 1 ◽

Oral Solution ◽

Open Label ◽

Randomized Crossover Study

Download Full-text

Bioavailability of Three Rufinamide Oral Suspensions Compared With the Marketed 400-mg Tablet Formulation: Results From a Randomized-Sequence, Open-Label, Four-Period, Four-Sequence Crossover Study in Healthy Subjects

Clinical Therapeutics ◽

10.1016/j.clinthera.2011.01.016 ◽

2011 ◽

Vol 33 (1) ◽

pp. 146-157 ◽

Cited By ~ 6

Author(s):

David John Critchley ◽

Jagadeesh Aluri ◽

Peter Boyd ◽

Matthew Whayman ◽

Milind Narurkar ◽

...

Keyword(s):

Crossover Study ◽

Healthy Subjects ◽

Tablet Formulation ◽

Open Label

Download Full-text

Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalicylic Acid in Fixed-Dose Combination with Clopidogrel Versus Enteric Aspirin in Chinese Subjects Under Fasting Conditions: A Phase 1, Open-Label, Randomized, Crossover Study

Advances in Therapy ◽

10.1007/s12325-020-01369-z ◽

2020 ◽

Vol 37 (6) ◽

pp. 2696-2709

Author(s):

Lu Wang ◽

Yujing Di ◽

Tingting Guo ◽

Jeffrey E. Ming ◽

Fangyuan Kong ◽

...

Keyword(s):

Acetylsalicylic Acid ◽

Crossover Study ◽

Phase 1 ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Open Label ◽

Average Bioequivalence ◽

Dose Combination ◽

Randomized Crossover Study ◽

Chinese Subjects

Download Full-text

A Phase 1, Open-Label, Single-Dose, Randomized, 3-Way Crossover Study to Assess the Pharmacokinetics and Safety of SYM-1219 Containing 2 g of Secnidazole Administered Orally as Granules in Pudding, Yogurt, or Applesauce in Healthy Female Volunteers

10.26226/morressier.57ea3d6ad462b8028d88ed3b ◽

2016 ◽

Author(s):

Helen S Pentikis

Keyword(s):

Single Dose ◽

Crossover Study ◽

Phase 1 ◽

Open Label ◽

Healthy Female

Download Full-text

Abstract LB-229: A phase 1 open-label fixed-sequence two-period crossover study of the effect of multiple doses of tamoxifen on palbociclib (PD-0332991) pharmacokinetics in healthy male volunteers

10.1158/1538-7445.am2014-lb-229 ◽

2014 ◽

Author(s):

Justin T. Hoffman ◽

Melissa O'Gorman ◽

Cho-Ming Loi ◽

Anna Plotka ◽

Tanya Boutros ◽

...

Keyword(s):

Crossover Study ◽

Phase 1 ◽

Healthy Male ◽

Open Label ◽

Fixed Sequence ◽

Healthy Male Volunteers ◽

Male Volunteers ◽

Multiple Doses

Download Full-text

Abstract CT419: A phase 1 randomized, open-label, 2-sequence, 2-period crossover study of the effect of multiple doses of palbociclib (PD-0332991) on midazolam pharmacokinetics in healthy women of non-childbearing potential

10.1158/1538-7445.am2014-ct419 ◽

2014 ◽

Cited By ~ 2

Author(s):

Justin T. Hoffman ◽

Anna Plotka ◽

Melissa O'Gorman ◽

Cho-Ming Loi ◽

Leonid Kirkovsky ◽

...

Keyword(s):

Crossover Study ◽

Phase 1 ◽

Open Label ◽

Childbearing Potential ◽

Healthy Women ◽

Multiple Doses

Download Full-text

A Phase 1, Single-Center, Single-Dose, Open-Label, Randomized, Crossover, Comparative Bioavailability And Food Effect Study To Compare BPS-314d-MR 15 µg And 60 µg Tablet Formulations To The Existing BPS-MR 60 µg Tablet Formulation In Healthy Volunteers

10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4784 ◽

2012 ◽

Author(s):

David W. Armstrong ◽

William Wargin ◽

David Mottola ◽

Eugene J. Sullivan

Keyword(s):

Single Dose ◽

Healthy Volunteers ◽

Food Effect ◽

Phase 1 ◽

Effect Study ◽

Tablet Formulation ◽

Single Center ◽

Open Label ◽

Comparative Bioavailability ◽

Tablet Formulations

Download Full-text

Bioavailability study of fixed-dose tablet versus capsule formulation of amlodipine plus benazepril: A randomized, single-dose, two-sequence, two-period, open-label, crossover study in healthy volunteers

Current Therapeutic Research ◽

10.1016/j.curtheres.2005.04.005 ◽

2005 ◽

Vol 66 (2) ◽

pp. 69-79 ◽

Cited By ~ 3

Author(s):

Kuo-Liong Chien ◽

Chia-Lun Chao ◽

Ta-Cheng Su

Keyword(s):

Single Dose ◽

Crossover Study ◽

Healthy Volunteers ◽

Fixed Dose ◽

Open Label ◽

Capsule Formulation ◽

Bioavailability Study ◽

Dose Tablet

Download Full-text

The effect of itraconazole on the pharmacokinetics of lorlatinib: results of a phase I, open-label, crossover study in healthy participants

Investigational New Drugs ◽

10.1007/s10637-019-00872-7 ◽

2019 ◽

Vol 38 (1) ◽

pp. 131-139 ◽

Cited By ~ 3

Author(s):

Maulik Patel ◽

Joseph Chen ◽

Stephanie McGrory ◽

Melissa O’Gorman ◽

Sunil Nepal ◽

...

Keyword(s):

Phase I ◽

Crossover Study ◽

Open Label ◽

Healthy Participants

Download Full-text

A Phase 1 Study to Assess the Relative Bioavailability, Food Effect, and Safety of a Tablet Formulation of GSK2838232, a Novel HIV Maturation Inhibitor in Healthy Participants After Single and Repeated Doses

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.820 ◽

2020 ◽

Vol 9 (8) ◽

pp. 972-977 ◽

Cited By ~ 1

Author(s):

Mark Johnson ◽

Roxanne C. Jewell ◽

Jianjun Gan ◽

Etienne Dumont ◽

Olivia Burns ◽

...

Keyword(s):

Food Effect ◽

Phase 1 ◽

Relative Bioavailability ◽

Tablet Formulation ◽

Phase 1 Study ◽

Maturation Inhibitor ◽

Repeated Doses ◽

Healthy Participants

Download Full-text